(Q46150594)

19 December 2017

title

Insights into modeling streptozotocin-induced diabetes in ICR mice (English)

1 reference

19 December 2017

4

Rimona Margalit

1 reference

19 December 2017

Inbar Elron-Gross

series ordinal

3

object named as

Inbar Elron-Gross

1 reference

19 December 2017

Yifat Glucksam

series ordinal

2

object named as

Yifat Glucksam

1 reference

19 December 2017

author name string

Yaron Dekel

series ordinal

1

1 reference

19 December 2017

publication date

1 February 2009

1 reference

19 December 2017

published in

Lab Animal

1 reference

19 December 2017

volume

38

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

55-60

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/laban0209-55

exact match

0 references

cites work

New model of progressive non-insulin-dependent diabetes mellitus in mice induced by streptozotocin.

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

The prevalence of diabetes and associated coronary risk factors in urban and rural older Mexican populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

Insulin structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Alternatives routes of insulin delivery.

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Concept, strategies, and feasibility of noninvasive insulin delivery

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

The mechanisms of alloxan- and streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Characterization of low dose streptozotocin-induced progressive diabetes in mice.

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Strain differences in the diabetogenic activity of streptozotocin in mice.

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Proinsulin is refractory to protein fibrillation: topological protection of a precursor protein from cross-beta assembly

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Antinociceptive effect of oxycodone in diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Effect of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in diabetic mice with sepsis

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Magnetically responsive polymeric microparticles for oral delivery of protein drugs

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Comparison of nerve growth factor mRNA expression in cardiac and skeletal muscle in streptozotocin-induced diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Rodent models of streptozotocin-induced diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis.

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Role of changes in cardiac metabolism in development of diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Genetics of type 2 diabetes mellitus and obesity--a review

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

A murine model of insulin-dependent diabetes mellitus resulting from the cumulative effects of the nondiabetogenic strain of encephalomyocarditis virus and a single low dose of streptozocin

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Diabetes teratogenicity in mice is accompanied with distorted expression of TGF-beta2 in the uterus

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Improved activity of streptozotocin-selected insulinoma cells following microencapsulation and transplantation into diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Glucose regulated proteins 78 protects insulinoma cells (NIT-1) from death induced by streptozotocin, cytokines or cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Suppressive effect of a hot water extract of adzuki beans (Vigna angularis) on hyperglycemia after sucrose loading in mice and diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Hepatic changes of mice in the subacute phase of streptozotocin (SZ)-induced diabetes

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Hepatic changes in the acute phase of streptozotocin (SZ)-induced diabetes in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Hepatocyte Growth Factor Preserves Beta Cell Mass and Mitigates Hyperglycemia in Streptozotocin-induced Diabetic Mice

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Beta-cell secretory dysfunction in the pathogenesis of low birth weight-associated diabetes: a murine model

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Treatment of diabetes mellitus to reduce its chronic cardiovascular complications

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Toward the improvement of diabetes treatment: recent developments in technical support

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Nongenetic mouse models of non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FLABAN0209-55

7 January 2021

Identifiers

DOI

10.1038/LABAN0209-55

1 reference

19 December 2017

1 reference

19 December 2017